• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

学习淀粉样 PET 结果的心理社会影响:一项观察性队列研究。

Psychosocial implications of learning amyloid PET results in an observational cohort.

机构信息

Department of Medicine, Division of Geriatrics & Gerontology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Geriatric Research Education and Clinical Center, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA.

出版信息

Alzheimers Dement. 2024 Sep;20(9):6579-6589. doi: 10.1002/alz.14153. Epub 2024 Aug 11.

DOI:10.1002/alz.14153
PMID:39129396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11497643/
Abstract

INTRODUCTION

Information on the psychosocial impact of Alzheimer's disease (AD) biomarker testing in adults at risk of AD is needed to inform best practices for communicating biomarker results.

METHODS

Ninety-nine cognitively unimpaired older adults learned amyloid positron emission tomography (PET) results (mean age = 72.0 ± 4.8, 95% White, 28% elevated amyloid). Linear mixed-effects regression models were used to test the main effects and interaction of PET result × time on psychosocial outcomes up to 6 months after learning results.

RESULTS

A significant interaction of PET result × time was observed for concern about AD (β = 0.28, p = 0.02) and intrusive thoughts and avoidance (β = -0.82, p < 0.001). A main effect of PET result was observed for AD test-related distress (β = 12.09, p < 0.001).

DISCUSSION

Cognitively unimpaired adults learning elevated-amyloid PET results reported mildly intrusive thoughts/avoidance initially following disclosure, but these symptoms decreased over time. Concern about AD dementia and AD biomarker test-related distress remained higher in elevated-amyloid compared to non-elevated-amyloid participants.

HIGHLIGHTS

Longitudinal assessment of psychosocial reactions after amyloid PET disclosure was conducted. Transient highly intrusive thoughts or avoidance after learning elevated amyloid results. Persistent test result-related distress after receiving elevated-amyloid results. There is increased concern about AD dementia after receiving elevated-amyloid results. Happiness and relief are experienced after receiving non-elevated-amyloid results.

摘要

简介

需要了解阿尔茨海默病(AD)生物标志物检测对处于 AD 风险中的成年人的心理社会影响信息,以便为交流生物标志物结果提供最佳实践。

方法

99 名认知正常的老年人学习了淀粉样蛋白正电子发射断层扫描(PET)结果(平均年龄为 72.0 ± 4.8,95%为白人,28%为淀粉样蛋白升高)。线性混合效应回归模型用于测试 PET 结果×时间对学习结果后 6 个月内心理社会结果的主要影响和相互作用。

结果

观察到 PET 结果×时间的显著相互作用,表现在对 AD 的担忧(β=0.28,p=0.02)和侵入性思维和回避(β=-0.82,p<0.001)。观察到 PET 结果对 AD 测试相关的痛苦的主要影响(β=12.09,p<0.001)。

讨论

认知正常的成年人在了解到淀粉样蛋白升高的 PET 结果后,报告说在披露后最初会出现轻度侵入性思维/回避,但这些症状随着时间的推移而减少。与非淀粉样蛋白升高的参与者相比,AD 痴呆和 AD 生物标志物测试相关的痛苦在淀粉样蛋白升高的参与者中仍然更高。

亮点

对淀粉样蛋白 PET 披露后心理社会反应进行了纵向评估。在学习淀粉样蛋白升高结果后,会出现短暂的高度侵入性思维或回避。在接收到淀粉样蛋白升高的结果后,会持续存在与测试结果相关的痛苦。在接收到淀粉样蛋白升高的结果后,对 AD 痴呆的担忧增加。在接收到非淀粉样蛋白升高的结果后,会感到幸福和宽慰。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11b/11497643/3ccba891b2c9/ALZ-20-6579-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11b/11497643/3ccba891b2c9/ALZ-20-6579-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11b/11497643/3ccba891b2c9/ALZ-20-6579-g001.jpg

相似文献

1
Psychosocial implications of learning amyloid PET results in an observational cohort.学习淀粉样 PET 结果的心理社会影响:一项观察性队列研究。
Alzheimers Dement. 2024 Sep;20(9):6579-6589. doi: 10.1002/alz.14153. Epub 2024 Aug 11.
2
Family members' perspectives on learning cognitively unimpaired older adults' amyloid-β PET scan results.家庭成员对认知正常的老年人淀粉样蛋白-β PET 扫描结果的学习的看法。
J Am Geriatr Soc. 2021 Nov;69(11):3203-3211. doi: 10.1111/jgs.17362. Epub 2021 Jul 12.
3
Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.认知正常成年人对淀粉样 PET 扫描结果披露的反应。
PLoS One. 2020 Feb 13;15(2):e0229137. doi: 10.1371/journal.pone.0229137. eCollection 2020.
4
Emotional distress following amyloid PET result disclosure: Heightened among those with cognitive symptoms.淀粉样蛋白PET结果披露后的情绪困扰:认知症状患者中更为严重。
Alzheimers Dement. 2025 Apr;21(4):e70121. doi: 10.1002/alz.70121.
5
Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults.认知正常的老年人对淀粉样蛋白正电子发射断层扫描生物标志物升高结果的理解。
JAMA Neurol. 2018 Jan 1;75(1):44-50. doi: 10.1001/jamaneurol.2017.2954.
6
Communicating Alzheimer's biomarker results to cognitively unimpaired research participants: Satisfaction, utility, and impact on research attitudes.向认知未受损的研究参与者传达阿尔茨海默病生物标志物检测结果:满意度、效用及对研究态度的影响
Alzheimers Dement (N Y). 2024 Jun 14;10(2):e12483. doi: 10.1002/trc2.12483. eCollection 2024 Apr-Jun.
7
Informing Alzheimer's Biomarker Communication: Concerns and Understanding of Cognitively Unimpaired Adults During Amyloid Results Disclosure.告知阿尔茨海默病生物标志物信息:在淀粉样蛋白检测结果披露期间,认知正常成年人的关注点和理解。
J Prev Alzheimers Dis. 2024;11(6):1572-1580. doi: 10.14283/jpad.2024.151.
8
Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial.在一项临床前阿尔茨海默病试验中,淀粉样蛋白状态升高的披露与长期自杀倾向无关。
Alzheimers Dement. 2025 Feb;21(2):e14623. doi: 10.1002/alz.14623.
9
Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.淀粉样蛋白和 Tau 预测认知和功能下降在认知正常的老年人:来自 A4 和 LEARN 研究的纵向数据。
J Prev Alzheimers Dis. 2024;11(4):802-813. doi: 10.14283/jpad.2024.122.
10
Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease Trial.在一项临床前阿尔茨海默病试验中对淀粉样蛋白成像的观点和看法。
J Prev Alzheimers Dis. 2024;11(6):1563-1571. doi: 10.14283/jpad.2024.157.

引用本文的文献

1
Communicating the risk of dementia: a scoping review.痴呆症风险的沟通:一项范围综述
BMJ Neurol Open. 2025 Jul 22;7(2):e001138. doi: 10.1136/bmjno-2025-001138. eCollection 2025.
2
Return of research results across the Alzheimer's Disease Research Centers network.阿尔茨海默病研究中心网络的研究结果反馈
Alzheimers Dement. 2025 Jun;21(6):e70418. doi: 10.1002/alz.70418.
3
Estimating the optimal cutoff for the IGT-AD Distress subscale adapted for amyloid PET results disclosure.估计适用于淀粉样蛋白PET结果披露的IGT-AD痛苦分量表的最佳临界值。

本文引用的文献

1
Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial.全球截断随机试验中认知未受损个体对阿尔茨海默病生物标志物披露的即时反应
Neurol Clin Pract. 2024 Apr;14(2):e200265. doi: 10.1212/CPJ.0000000000200265. Epub 2024 Jan 12.
2
Anticipated Psychological or Behavioral Reactions to Learning Alzheimer Biomarker Results: Associations With Contextual Factors.得知阿尔茨海默病生物标志物检测结果后的预期心理或行为反应:与情境因素的关联。
Alzheimer Dis Assoc Disord. 2023;37(4):282-289. doi: 10.1097/WAD.0000000000000586. Epub 2023 Oct 12.
3
Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.
Alzheimers Dement (N Y). 2025 Jun 7;11(2):e70116. doi: 10.1002/trc2.70116. eCollection 2025 Apr-Jun.
4
Emotional distress following amyloid PET result disclosure: Heightened among those with cognitive symptoms.淀粉样蛋白PET结果披露后的情绪困扰:认知症状患者中更为严重。
Alzheimers Dement. 2025 Apr;21(4):e70121. doi: 10.1002/alz.70121.
信息披露:简短教育干预对研究参与者关于阿尔茨海默病生物标志物知识的影响。
J Alzheimers Dis. 2023;96(2):515-522. doi: 10.3233/JAD-230732.
4
Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort.虚拟阿尔茨海默病生物标志物披露的可行性:一项观察性队列研究的结果
Alzheimers Dement (N Y). 2023 Jul 29;9(3):e12413. doi: 10.1002/trc2.12413. eCollection 2023 Jul-Sep.
5
Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta-analysis of empirical data.与无痴呆个体共享阿尔茨海默病生物标志物的影响:基于实证数据的系统评价和荟萃分析。
Alzheimers Dement. 2023 Dec;19(12):5773-5794. doi: 10.1002/alz.13410. Epub 2023 Jul 26.
6
Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum.阿尔茨海默病生物标志物检测及在疾病连续体中的结果披露
Neurology. 2023 May 23;100(21):1010-1019. doi: 10.1212/WNL.0000000000206891. Epub 2023 Jan 31.
7
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline.主观认知下降成人接受淀粉样蛋白正电子发射断层扫描成像结果披露后的心理症状分析。
JAMA Netw Open. 2023 Jan 3;6(1):e2250921. doi: 10.1001/jamanetworkopen.2022.50921.
8
Trajectory of clinical symptoms in relation to amyloid chronicity.与淀粉样蛋白慢性病程相关的临床症状轨迹。
Alzheimers Dement (Amst). 2022 Sep 20;14(1):e12360. doi: 10.1002/dad2.12360. eCollection 2022.
9
Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment.向无认知障碍的研究参与者披露淀粉样蛋白成像结果的短期心理结果。
JAMA Neurol. 2020 Dec 1;77(12):1504-1513. doi: 10.1001/jamaneurol.2020.2734.
10
A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairment.一项针对轻度认知障碍患者淀粉样蛋白正电子发射断层扫描结果披露的随机对照试验。
Alzheimers Dement. 2020 Sep;16(9):1330-1337. doi: 10.1002/alz.12129. Epub 2020 Jun 26.